Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116828233 | 11682823 | 3 | F | 201412 | 20160721 | 20151029 | 20160802 | EXP | US-ABBVIE-15K-163-1489253-00 | ABBVIE | 58.53 | YR | M | Y | 89.44000 | KG | 20160802 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116828233 | 11682823 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 1041562 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | ||||||
| 116828233 | 11682823 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | 1041562 | 125057 | |||||||||||
| 116828233 | 11682823 | 3 | SS | TRIPTYLINE | AMITRIPTYLINE HYDROCHLORIDE | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 116828233 | 11682823 | 4 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | 0 | ||||||||||||
| 116828233 | 11682823 | 5 | C | ETODOLAC. | ETODOLAC | 1 | 0 | ||||||||||||
| 116828233 | 11682823 | 6 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | ||||||||||||
| 116828233 | 11682823 | 7 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | 0 | ||||||||||||
| 116828233 | 11682823 | 8 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 116828233 | 11682823 | 9 | C | DILTIAZEM HCL | DILTIAZEM HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 116828233 | 11682823 | 10 | C | BACLOFEN. | BACLOFEN | 1 | 0 | ||||||||||||
| 116828233 | 11682823 | 11 | C | TRAMADOL. | TRAMADOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116828233 | 11682823 | 1 | Psoriasis |
| 116828233 | 11682823 | 2 | Psoriatic arthropathy |
| 116828233 | 11682823 | 3 | Product used for unknown indication |
| 116828233 | 11682823 | 4 | Hypertension |
| 116828233 | 11682823 | 5 | Product used for unknown indication |
| 116828233 | 11682823 | 6 | Product used for unknown indication |
| 116828233 | 11682823 | 7 | Product used for unknown indication |
| 116828233 | 11682823 | 8 | Product used for unknown indication |
| 116828233 | 11682823 | 9 | Hypertension |
| 116828233 | 11682823 | 10 | Product used for unknown indication |
| 116828233 | 11682823 | 11 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116828233 | 11682823 | HO |
| 116828233 | 11682823 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116828233 | 11682823 | Ankylosing spondylitis | |
| 116828233 | 11682823 | Cervical spinal stenosis | |
| 116828233 | 11682823 | Decreased appetite | |
| 116828233 | 11682823 | Insomnia | |
| 116828233 | 11682823 | Migraine | |
| 116828233 | 11682823 | Mobility decreased | |
| 116828233 | 11682823 | Muscular weakness | |
| 116828233 | 11682823 | Musculoskeletal pain | |
| 116828233 | 11682823 | Procedural pain | |
| 116828233 | 11682823 | Psoriasis | |
| 116828233 | 11682823 | Rotator cuff syndrome | |
| 116828233 | 11682823 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116828233 | 11682823 | 1 | 20141219 | 0 |